The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chukanova A.S.

Pirogov Russian National Research Medical University

Chukanova E.I.

Pirogov Russian National Research Medical University

Radionova D.M.

Pirogov Russian National Research Medical University

Bagmanyan S.D.

Pirogov Russian National Research Medical University

The cerebral microangiopathy

Authors:

Chukanova A.S., Chukanova E.I., Radionova D.M., Bagmanyan S.D.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(3‑2): 52‑58

DOI: 10.17116/jnevro202212203252

Views: 54266

Downloaded: 524

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Chukanova AS, Chukanova EI, Radionova DM, Bagmanyan SD. The cerebral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(3‑2):52‑58. (In Russ.)
https://doi.org/10.17116/jnevro202212203252

 
МСФ на ЯМ
Close metadata
Recommended articles:
The rela­tionship between the deve­lopment of post-stroke cognitive impairment and changes in the coagulation component of hemo­stasis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):23-29
The effect of inso­mnia on mild cognitive impairment in patients with vascular risks: resu­lts of a three-year longitudinal study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):30-36
Prevalence of cognitive impairment in older adults in the Russian Fede­ration. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11
Cognitive impairment in cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16
Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer’s disease and vascular cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):17-24
Cognitive impairment in patients with arte­rial hype­rtension. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):41-48
Features of the clinical and neuroimaging picture in patients with early-onset Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):56-63
Identifying the neurostimulation target for treatment of cognitive impairment in aging and early cere­bral small vessel disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):34-41
Asthenic diso­rders correction with Reco­gnan. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):57-62
Asso­ciations between components of meta­bolic syndrome and cognitive impairment in patients with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):82-87

The review article highlights the main points of the development of cerebral microangiopathy — «small vessel diseases». Cerebral microangiopathy or small vessel disease. Cerebral microangiopathy is one of the leading causes of the development of acute and/or chronic cerebral circulatory disorders and cognitive disorders up to severe dementia. The article analyzes the relationship of pathoanatomic, neuroimaging and clinical manifestations of the course of cerebral microangiopathy.

Keywords:

cerebral microangiopathy
small vessel disease
cognitive impairment
dementia
neuroimaging

Authors:

Chukanova A.S.

Pirogov Russian National Research Medical University

Chukanova E.I.

Pirogov Russian National Research Medical University

Radionova D.M.

Pirogov Russian National Research Medical University

Bagmanyan S.D.

Pirogov Russian National Research Medical University

Received:

18.10.2021

Accepted:

19.11.2021

List of references:

  1. Gusev EI, Chukanova EI, Chukanova AS. Khronicheskaya tserebrovaskulyarnaya nedostatochnost’ (faktory riska, patogenez, klinika, lechenie). M.: AST; 2018. (In Russ.).
  2. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689-701.  https://doi.org/10.1016/s1474-4422(10)70104-6
  3. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab. 2008;28(12):1877-1891. https://doi.org/10.1038/jcbfm.2008.91
  4. Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol. 1979;36(2):65-73.  https://doi.org/10.1001/archneur.1979.00500380035003
  5. Fisher CM. Lacunar strokes and infarcts: a review. Neurology. 1982;32(8):871-876.  https://doi.org/10.1212/wnl.32.8.871
  6. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27(9):1641-1647. https://doi.org/10.1161/01.str.27.9.1641
  7. Petito CK, Olarte JP, Roberts B, Nowak TS Jr, Pulsinelli WA. Selective glial vulnerability following transient global ischemia in rat brain. J Neuropathol Exp Neurol. 1998;57(3):231-238.  https://doi.org/10.1097/00005072-199803000-00004
  8. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol. 1986;19(3):253-262.  https://doi.org/10.1097/00002093-198701000-00036
  9. Ihara, Yamamoto M and Y. Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease. Stroke. 2016;47(2):554-560.  https://doi.org/10.1161/strokeaha.115.009627
  10. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991;30(5):637-649.  https://doi.org/10.1002/ana.410300503
  11. Rost NS, Etherton M. Cerebral Small Vessel Disease [published correction appears in Continuum (Minneap Minn). 2020;26(3):826-827]. Continuum (Minneap Minn). 2020;26(2):332-352.  https://doi.org/10.1212/con.0000000000000841
  12. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822-838.  https://doi.org/10.1016/s1474-4422(13)70124-8
  13. Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11(3):157-165.  https://doi.org/10.1038/nrneurol.2015.10
  14. Burton EJ, Kenny RA, O’Brien J, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke. 2004;35(6):1270-1275. https://doi.org/10.1161/01.str.0000126041.99024.86.
  15. Lambert C, Benjamin P, Zeestraten E, Lawrence AJ, Barrick TR, Markus HS. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease. Brain. 2016;139(Pt 4):1136-1151. https://doi.org/10.1093/brain/aww009
  16. Curnes JT, Burger PC, Djang WT, Boyko OB. MR imaging of compact white matter pathways. AJNR Am J Neuroradiol. 1988;9(6):1061-1068. https://pubmed.ncbi.nlm.nih.gov/3143230/
  17. Cambron M, D’Haeseleer M, Laureys G, Clinckers R, Debruyne J, De Keyser J. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab. 2012;32(3):413-424.  https://doi.org/10.1038/jcbfm.2011.193
  18. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke. 1997;28(3):491-499.  https://doi.org/10.1161/01.str.28.3.491
  19. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6(7):611-619.  https://doi.org/10.1016/S1474-4422(07)70170-9
  20. Del Bene A, Makin SD, Doubal FN, Inzitari D, Wardlaw JM. Variation in risk factors for recent small subcortical infarcts with infarct size, shape, and location. Stroke. 2013;44(11):3000-3006. https://doi.org/10.1161/strokeaha.113.002227
  21. Chen CF, Lan SH, Khor GT, Lai CL, Tai CT. Cognitive dysfunction after acute lacunar infarct. Kaohsiung J Med Sci. 2005;21(6):267-271.  https://doi.org/10.1016/s1607-551x(09)70199-8
  22. Grau-Olivares M, Arboix A. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother. 2009;9(8):1201-1217. https://doi.org/10.1586/ern.09.73
  23. Tatemichi TK, Desmond DW, Prohovnik I, et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology. 1992;42(10):1966-1979. https://doi.org/10.1212/wnl.42.10.1966
  24. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50(8):873-880.  https://doi.org/10.1001/archneur.1993.00540080076020
  25. Van Zandvoort MJ, Kappelle LJ, Algra A, De Haan EH. Decreased capacity for mental effort after single supratentorial lacunar infarct may affect performance in everyday life. J Neurol Neurosurg Psychiatry. 1998;65(5):697-702.  https://doi.org/10.1136/jnnp.65.5.697
  26. Leskelä M, Hietanen M, Kalska H, et al. Executive functions and speed of mental processing in elderly patients with frontal or nonfrontal ischemic stroke. Eur J Neurol. 1999;6(6):653-661.  https://doi.org/10.1046/j.1468-1331.1999.660653.x
  27. Tatemichi TK. How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology. 1990;40(11):1652-1659. https://doi.org/10.1212/wnl.40.11.1652
  28. Samuelsson M, Söderfeldt B, Olsson GB. Functional outcome in patients with lacunar infarction. Stroke. 1996;27(5):842-846.  https://doi.org/10.1161/01.STR.27.5.842
  29. Pasi M, Boulouis G, Fotiadis P, et al. Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease. Neurology. 2017;88(23):2162-2168. https://doi.org/10.1212/wnl.0000000000004007
  30. Ding J, Sigurdsson S, Garcia M, et al. Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. JAMA Neurol. 2015;72(6):682-688.  https://doi.org/10.1161/circ.131.suppl_1.mp90
  31. Cordonnier C, van der Flier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology. 2006;66(9):1356-1360. https://doi.org/10.1212/01.wnl.0000255961.93980.1c
  32. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol. 1968;12(1):1-15.  https://doi.org/10.1007/BF00685305.
  33. Fisher CM. Lacunar strokes and infarcts: a review. Neurology. 1982;32:871.  https://doi.org/10.1212/WNL.32.8.871
  34. Poels MM, Ikram MA, van der Lugt A, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012;78(5):326-333.  https://doi.org/10.1212/wnl.0b013e3182452928
  35. Akoudad S, Wolters FJ, Viswanathan A, et al. Association of Cerebral Microbleeds With Cognitive Decline and Dementia. JAMA Neurol. 2016;73(8):934-943.  https://doi.org/10.1001/jamaneurol.2016.1017
  36. Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain. 2004;127(Pt 10):2265-2275. https://doi.org/10.1093/brain/awh253
  37. Smith EE, Gurol ME, Eng JA, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology. 2004;63(9):1606-1612. https://doi.org/10.1212/01.wnl.0000142966.22886.20
  38. Greenberg SM. Cerebral amyloid angiopathy and vessel dysfunction. Cerebrovasc Dis. 2002;13(suppl 2):42-47.  https://doi.org/10.1159/000049149
  39. Kwa VI, Franke CL, Verbeeten B, Stam J. Silent intracerebral microhemorrhages in patients with ischemic stroke. Amsterdam Vascular Medicine Group. Ann Neurol. 1998;44(3):372-377.  https://doi.org/10.1002/ana.410440313
  40. Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer’s disease: innocent observation or key player? Brain. 2011;134(Pt 2):335-344.  https://doi.org/10.1093/brain/awq321
  41. Drachman DA. The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer’s disease. Alzheimers Dement. 2014;10(3):372-380.  https://doi.org/10.1016/j.jalz.2013.11.003

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.